Antimicrobial therapy in older adults: profile of use and evaluation of the quality of prescription
Objectives: To analyze the point prevalence of antimicrobial agent use by older adults and to determine the quality of use in a teaching hospital. A pharmacoepidemiological, observational study. Methods: Retrospective collection of clinical, microbiological and pharmacotherapeutic data in medical records. Inclusion criteria: age ≥ 60 years old, in use of one or more antimicrobial agents. The resistant microorganisms classified as priority pathogens by the World Health Organization (WHO) were identified. The quality of antimicrobial agent use according to quality indicators described by Van den Bosch et al. (2015) was determined. A descriptive statistical analysis was performed. Results: Of the 130 hospitalized older adult individuals, 40.8% were using one or more antimicrobials agents on the day of point prevalence. Among the 50 resistant microorganisms identified in the cultures, 54.0% corresponded to pathogens of critical priority. Antibiotic glycopeptides (14.9%) and penicillins associated with beta-lactamase inhibitors (13.8%) were the most prescribed classes of antimicrobial agents. The Quality Indicators (QIs) of antimicrobial therapy demonstrated more frequent inadequacy regarding therapeutic monitoring, sequential therapy and blood culture request. Conclusions: The prevalence of antimicrobial agent use in older adults was high. Empirical therapy is often developed in line with that advocated by the Infection Control Commission. The high isolation of critical pathogens according to the WHO, evidences the importance of actions to ensure the rational use of drugs in the institution. The QIs demonstrated the need to implement guidelines for systematizing therapeutic antimicrobial agent monitoring in the institution and educational action on the process of requesting blood cultures.
How to Cite
Copyright (c) 2020 RBFHSS and the Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.